Dr Max Feltham MSc, PhD

Dr Max Feltham

Institute of Applied Health Research
Quality Assurance Manager
Academic Related

Contact details

Address
Birmingham Clinical Trials Unit (BCTU)
Public Health Building
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Max is a committed quality assurance manager at Birmingham Clinical Trials Unit (BCTU) where he leads the quality management system to ensure the trials are compliant with regulatory requirements and patient safety and data integrity are respected. He has research experience in the primary care and secondary care sector. 

Max joined BCTU in 2016 as the Team Lead for Women’s Health, where he led a team of trial management staff responsible for administration of a portfolio of clinical trials in obstetrics and gynaecology. The findings from the completed clinical trials have been published in major medical journals. Since 2019 he has been the Quality Assurance Manager at BCTU.

Qualifications

  • PhD in Perceptual Motor Control, VU University Amsterdam, 2009
  • PhD in Neural and Visual Control of Human Movement, Manchester Metropolitan University, 2009
  • MSc in Human Movement Sciences, VU University Amsterdam, 2005

Biography

Max was awarded MSc. (2005) in Human Movement Science, with a major in Ergonomics from the VU University Amsterdam, The Netherlands.  As part of his MSc. degree he spent six months at the Human Neurology Unit, University of Queensland, Australia. In 2009 he received a double doctorate in Neural and Visual Control of Human Movement from Manchester Metropolitan University, United Kingdom and the VU University Amsterdam, The Netherlands. His PhD thesis was entitled "The 'mirror box' illusion: Manipulation of visual information during bimanual coordination in children with and without spastic hemiparetic cerebral palsy".

Max started working as a Post-Doctoral Research Fellow at Oxford Brookes University to investigate the effect of exercise programmes on the cardiovascular system in people with multiple sclerosis and to develop a measurement tool to monitor gait patterns in people with a long-term neurodegenerative disease.  Max joined the University of Birmingham in August 2011 in the Rehabilitation Team at Primary Care & Clinical Sciences, where he worked on the OTCH (phase III cluster randomised controlled trial) and FACE TIA (controlled cohort study) trials. He became a Research Manager in Primary Care in June 2013, where he prepared, developed and led on patient recruitment for clinical trials in Primary Care. Furthermore, he supervised two PhD projects investigating constraint induced movement therapy in pre-school children with hemiplegic cerebral palsy and missed opportunities for primary prevention of stroke and transient ischaemic attack (TIA) and residual impairments after TIA.

Teaching

Research Methods Course for Clinical Trials

Research

The University of Birmingham Clinical Trials Unit (BCTU) is a leading national clinical trials unit specialising in the design, conduct and analysis of definitive clinical trials and test evaluation studies.

Research Groups and Centres:

 Birmingham Clinical Trials Unit (BCTU)

Other activities

  • Society for Research in Rehabilitation (SRR)
  • Dutch Society of Human Movement Sciences (VvBN)
  • UK Clinical Research Collaboration (UKCRC)

Publications

Christmas PM, Sackley C, Feltham MG, Cummins C (2018). A randomized controlled trial to compare two methods of constraint-induced movement therapy to improve functional ability in the affected upper limb in pre-school children with hemiplegic cerebral palsy: CATCH TRIAL. Clinical Rehabilitation, 32:909-918. 

Turner GM, Calvert M, Feltham MG, Ryan R, Fitzmaurice D, Cheng KK, Marshall T (2016). Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis. PLoS medicine, 13:e1002169. 

Feltham MG, Collett J, Izadi H, Wade DT, Morris MG, Meaney AJ, Howells K, Sackley C, Dawes H (2013). Cardiovascular adaptation in people with multiple sclerosis following a twelve week exercise programme suggest deconditioning rather than autonomic dysfunction caused by the disease. Results from a randomized controlled trial. European Journal of Physical and Rehabilitation Medicine, 49:765-74.

View all publications in research portal